The researchers found that a biomarker in the blood called neurofilament light chain (NfL) increased after menopause. This ...
After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to a study published online in Neurology.
Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...
COVID-19 infection is not associated with immediate changes in multiple sclerosis symptom severity or disability.
Third, clear accountability and reporting standards are essential. Regulatory frameworks must include incentives for financial services institutions to disclose their progress on universal inclusion ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...
The average wait time between a referral and neurologist visit was more than a month among older adults, with longer wait ...
Saad Z. Usmani, MD, MBA, FACP, discusses how the definition of the transplant-ineligible population for multiple myeloma is evolving while also addressing the challenges of standardizing minimal ...
Decades of subtle health changes went by without answers. When worsening disability led Roger to a multiple sclerosis (MS) ...
A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...
Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback